| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total cost and expenses | 502,745 | 495,514 | 1,045,242 | 444,976 |
| Operating (loss) income | -103,389 | 115,577 | -300,386 | 22,196 |
| Loss on debt extinguishment | -138,613 | - | - | - |
| Other income, net | 47,953 | 38,061 | -83,132 | 11,810 |
| Total other (loss) income, net | -90,660 | - | - | 11,810 |
| (loss) income before income tax (benefit) expense | -194,049 | 153,638 | -383,518 | 34,006 |
| Income tax (benefit) expense | -14,102 | -43,254 | 63,990 | 395 |
| Net (loss) income | -179,947 | 196,892 | -447,508 | 33,611 |
| Unrealized gains on investments, net of tax | 271 | -85 | - | 3,275 |
| Total other comprehensive income | 271 | -85 | - | 3,275 |
| Comprehensive (loss) income | -179,676 | 196,807 | - | 36,886 |
| Basic | 100,237,000 | 98,005,000 | 97,362,000 | 95,390,000 |
| Diluted | -1.8 | 1.89 | -4.6 | 0.34 |
| Diluted | 100,237,000 | 106,623,000 | 97,362,000 | 100,448,000 |
| Earnings per share, basic | -1.8 | 2.01 | -4.6 | 0.35 |
Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT)